{"id":27627,"date":"2020-01-01T00:00:00","date_gmt":"2020-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/efficacy-and-safety-of-early-treatment-with-sarilumab-in-hospitalised-adults-with-covid-19-presenting-cytokine-release-syndrome-saricor-study-protocol-of-a-phase-ii-open-label-randomised-multice\/"},"modified":"2020-01-01T00:00:00","modified_gmt":"2020-01-01T00:00:00","slug":"efficacy-and-safety-of-early-treatment-with-sarilumab-in-hospitalised-adults-with-covid-19-presenting-cytokine-release-syndrome-saricor-study-protocol-of-a-phase-ii-open-label-randomised-multice","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/efficacy-and-safety-of-early-treatment-with-sarilumab-in-hospitalised-adults-with-covid-19-presenting-cytokine-release-syndrome-saricor-study-protocol-of-a-phase-ii-open-label-randomised-multice\/","title":{"rendered":"Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial"},"content":{"rendered":"
Lopez, RL; Fernandez, SC; Perez, LL; Palacios, AR; Fernandez-Roldan, MC; Alonso, EA; Camacho, IP; Rodriguez-Bano, J; Merchante, N; Olalla, J; Esteban-Moreno, MA; Santos, M; Luque-Pineda, A; Torre-Cisneros, J – 2020<\/p>","protected":false},"excerpt":{"rendered":"
Lopez, RL; Fernandez, SC; Perez, LL; Palacios, AR; Fernandez-Roldan, MC; Alonso, EA; Camacho, IP; Rodriguez-Bano, J; Merchante, N; Olalla, J; Esteban-Moreno, MA; Santos, M; Luque-Pineda, A; Torre-Cisneros, J – 2020<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1580],"tags":[],"acf":[],"yoast_head":"\n